DFX Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Venture Capital Intelligence at $199 a month for every name. Every figure, date and source on this page is public either way.
Firms / H•••••••• I• A•••••• A•
H•••••••• I• A•••••• A•
Micro VC · probableStockholmh••••••••.seSEC exempt reporting adviseremerging managerpart of H••••••••
One of 5 advisers that share h••••••••.se; the firm is H••••••••. H•••••••• A•••••• A•, H•••••••• V•• A•••••• A•, H•••••••• V••• A•••••• A•, O•• V• A•••••• A•. Each keeps its own CRD, funds and filings; the grouping is the website each swore to on Form ADV and is recomputed every pass.
••• Locked
venture manager, reported GAV $3.4M across 1 vehicles
Importance
27
moderate
Active deployment
30
moderate
Emerging
69
high
Completeness
63
high
Freshness
98
high
Research priority
30
moderate
Identity and regulatory footprint
- Headquarters
- Stockholm, Swedenadviserinfo.sec.gov
- Office address
- ••• Lockedadviserinfo.sec.gov
- Business phone
- ••• Lockedadviserinfo.sec.gov
- Website
- h••••••••.se
- SEC adviser type
- exempt reporting adviseradviserinfo.sec.gov
- SEC exemption claimed
- private fund adviseradviserinfo.sec.gov
- Latest Form ADV
- Mar 28, 2024
- Private funds reported
- 1 (1 venture capital funds)adviserinfo.sec.gov
- Private fund gross assets
- $3.4Madviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
- Owners on Schedule A
- H•••••••• I• H•••••• A• (Direct Owner), E
- business email
- tyra.kuller@healthcap.euhealthcap.eupublished by the subject
- business email
- carl.kilander@healthcap.euhealthcap.eupublished by the subject
- business phone
- +46 8 4425850adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
38 observed deals
Stated (the firm’s website)
- Sectors
- healthcare, biotech, climate, media
- Stages
- not stated or not yet read
- Geography
- global, globally
- Check size
- not stated; DFX does not estimate checks from round sizes
- Self-described
- venture capital
Observed (from deals on record)
Stage at participation: no observed deals yet
Stage at first entry: no observed deals yet
Sectors
unknown 92%Biotechnology 8%
lead rate n/afollow-on rate n/anew logos, 12 months 38
Funds and vehicles
1 reported
| Vehicle | Type | Vintage | Lifecycle | Reported GAV | Owners | Form D sold | Latest Form D |
|---|---|---|---|---|---|---|---|
| H•••••••• I• D• A• | Fund | unknown | Unknown | $3.4M Mar 28, 2024 | 17 | unknown | unknown |
GAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.
Investment team
26 current, 0 departed
J••••••• P••••••
AssociateAssociate | MSc
N•••••• P•••
AssociateAssociate I BSc
N••• B•••••
AssociateM•••••• Associate I MD
S••••• D•••••
AssociateAssociate | MD PhD
T••••• R••••••
General partnerDirector, GP | MSc PhD
V•••••• M•••••
General partnerDirector, GP | MSc
S•••• W•••••••••
OtherInvestment Monitor
A••• V••••
PartnerPartner | MSc
A••• F•••••••
PartnerPartner and Chairman | LLM MBA
C••• K•••••••
PartnerPartner | MD PhD
D••••• K•••••••
PartnerPartner | MSc
F•••••• B•••••••
PartnerGeneral Manager | MSc
J•••• C•••••••••
PartnerPartner | MD PhD
K••••••• E•••••
PartnerPartner | LLM
M•• O•••••••
PartnerPartner | MSc
P•• S•••••••••
PartnerPartner | MSc
S•••••• L•••••••••
PartnerPartner | MSc
M••••• S••••••
Platform and operationsHead of Compliance I MSc
N•••••• S••••••
Platform and operationsOffice Manager
B•••• O•••••••
PrincipalDirector · since Apr 1, 2023
K••••••• E•••••
PrincipalDirector · since Sep 1, 2022
M••••• S••••
PrincipalDirector · since Apr 1, 2023
O••• R• S••••
PrincipalDirector I MD MBA
C••••••••• D••••••••
Venture partnerVenture Partner | MD PhD
E•••• S••••••
Venture partnerVenture Partner | MD PhD
G•••• V• B•••••
Venture partnerVenture Partner | MSc
Investments on record
38 edges, 38 companies, 0 partner-attributed
“This investor” is the amount disclosed for this investor alone; it is unknown unless a source said it. The round size is the whole round.
Co-investors
19 relationships from shared deals, counted for the whole firm
Driven, LLC 1 shared · one timeMitsui & Co. Global Investment, Inc. 1 shared · one timeBiogeneration III Services B.V. 1 shared · one timeOmega Fund Management, LLC 1 shared · one timeAsset Management Ventures, LLC 1 shared · one timeSofinnova Investments, Inc. 1 shared · one timeHBM Healthcare Investments 1 shared · one timeGrdnt LLC 1 shared · one timeAvoro Capital A••••••s LLC 1 shared · one timeCrane Venture Partners LLP 1 shared · one timeSandwater 1 shared · one time · they led 1 · we led 1Lifeline Ventures 1 shared · one time · we led 1Sofinnova Partners 1 shared · one time · they led 1Maj Invest Equity 1 shared · one timeNovo Holdings 1 shared · one timeAccess Biotechnology 1 shared · one timeInvus 1 shared · one timeAvoro Ventures 1 shared · one timeDeep Track Capital 1 shared · one time
Limited partners
0 disclosed
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.
Timeline
9 dated events
- Sep 16, 2026H••••••••• no longer listed on H•••••••• I• A•••••• A•'s portfolio pageRemoved from portfolio pagePortfolioInferenceH•••••••••Venture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026m••••••••• s••••••• no longer listed on H•••••••• I• A•••••• A•'s portfolio pageRemoved from portfolio pagePortfolioInferencem••••••••• s•••••••Venture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026a••••••••• e••••••••• no longer listed on H•••••••• I• A•••••• A•'s portfolio pageRemoved from portfolio pagePortfolioInferencea••••••••• e•••••••••Venture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026h••••••••• t••••••••• no longer listed on H•••••••• I• A•••••• A•'s portfolio pageRemoved from portfolio pagePortfolioInferenceh••••••••• t•••••••••Venture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026p•••••••• e••••••• no longer listed on H•••••••• I• A•••••• A•'s portfolio pageRemoved from portfolio pagePortfolioInferencep•••••••• e•••••••Venture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026d••• v••• t••••••••• no longer listed on H•••••••• I• A•••••• A•'s portfolio pageRemoved from portfolio pagePortfolioInferenced••• v••• t•••••••••Venture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026l•• m•••••••• w••••• h•••••• no longer listed on H•••••••• I• A•••••• A•'s portfolio pageRemoved from portfolio pagePortfolioInferencel•• m•••••••• w••••• h••••••Venture organization websites (about, team, portfolio, thesis, news pages)
- Mar 28, 2024H•••••••• I• A•••••• A• first filed Form ADV (ERA)First SEC adviser filingOrganizationFactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 28, 2024H•••••••• I• D• A• first reported on Form ADV by H•••••••• I• A•••••• A• (Venture Capital Fund), GAV $3,440,917Fund first reported on Form ADVFundsFactH•••••••• I• D• A•SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Classification history
- Sep 12, 2026Micro VC (probable, 80%, cls-1)venture manager, reported GAV $3.4M across 1 vehicles
Evidence
33 observations from 2 sources